Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2022 No.04

Total 14 articles

The technology development trends in the field of artificial intelligence-assisted drug discovery based on patent analysisZHANG Ting, CHEN Juan, OUYANG Zhao-lian

305-311

Study on the impact heterogeneity of government subsidies and R&D investment on pharmaceutical enterprise performanceYANG Huan, WANG Jia-luo, GAO Zi-wen, CHU Shu-zhen

312-318

A brief analysis on the influence of the prior art with the same reaction site on the inventiveness assessment of synthetic method inventionWANG Lei, XU Wei

319-322

Background and key elements of"Guidance for Writing Pediatric Information in Labelings of Chemical Drugs and Biological Products ( Trial)"GENG Ying, ZHANG Hao, WANG Li-qing, LIANG Yu-guang, WANG Xiao-chuan, SUN Yan-zhe, LI Qiang, WANG Xiao-ling, YANG Zhi-min

323-328

Progress in research on drug metabolism in juvenile animalsLI Guang-lu, ZHANG Wen-peng, WU Chun-qi, ZHUANG Xiao-mei, ZHANG Tian-hong, WANG Quan-jun

329-336

Study on proficiency testing of determination of aflatoxin B1 residues in Polygalae radixLI Yao-lei, LI Hai-liang, ZAN Ke, WANG Dan-dan, XIANG Xin-hua, JIN Hong-yu, MA Shuang-cheng

337-342

An update on the combinations with β-lactamase inhibitorsZONG Hui, SUN Yu-fang, CHEN Si-min, AN Mao-mao, SHEN Hui

343-351

Research progress on in vitro models to study drug delivery in the posterior segment of the eyeLI Ya-min, CHEN Xue-feng, LIANG Li-na

352-356

Research on randomized,open label,double-period,double-cross bioequivalence trial of lenvatinib mesylate capsulesSONG Hao-jing, QIU Bo, SUN Xue, GUO Ni-ni, HU Yi-ting, BAI Wan-jun, GUO Cai-hui, DONG Zhan-jun

357-361

In silico study of the anti-inflammatory activity of Portulaca oleracea L. ingredientsLV Jun-ping, ZHOU Lu, SHI Dong-xu, A Ru-na, PANG Zong-ran, LU Bi-nan

369-375